{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:09:48Z","timestamp":1711670988489},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1985,12]]},"DOI":"10.1212\/wnl.35.12.1805","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T12:34:39Z","timestamp":1336912479000},"page":"1805-1805","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Beta\u2010adrenergic treatment of hyperkalemic periodic paralysis"],"prefix":"10.1212","volume":"35","author":[{"given":"Erich W.","family":"Streib","sequence":"first","affiliation":[{"name":"Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.35.12.1805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:27:01Z","timestamp":1711643221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.35.12.1805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1985,12]]}},"alternative-id":["10.1212\/WNL.35.12.1805"],"URL":"https:\/\/doi.org\/10.1212\/wnl.35.12.1805","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,12]]}}}